SEARCH

SEARCH BY CITATION

References

  • Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S. & Sunyaev, S. R. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7, 248249.
  • Andersen, L. B., Ballester, R., Marchuk, D. A., Chang, E., Gutmann, D. H., Saulino, A. M., Camonis, J., Wigler, M. & Collins, F. S. (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13, 487495.
  • Ars, E., Serra, E., Garcia, J., Kruyer, H., Gaona, A., Lazaro, C. & Estivill, X. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9, 237247.
  • Ars, E., Kruyer, H., Morell, M., Pros, E., Serra, E., Ravella, A., Estivill, X. & Lazaro, C. (2003) Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40, e82.
  • Bendova, S., Krepelova, A., Petrak, B., Kinstova, L., Musova, Z., Rausova, E. & Marikova, T. (2007) Novel mutations in the NF1 gene in Czech patients with neurofibromatosis type 1. J Mol Neurosci 31, 273279.
  • Bolcekova, A., Nemethova, M., Zatkova, A. K., Hlinkova, K., Pozgayova, S., Hlavata, A., Kadasi, L., Durovcikova, D., Gerinec, A., Husakova, K., Pavlovicova, Z., Holobrada, M., Kovacs, L. & Ilencikova, D. (2013) Clusterring of mutations in the 5’ tertile of the NF1 gene in Slovak patients with optic pathway glioma. Neoplasma 60, in press.
  • Brems, H., Chmara, M., Sahbatou, M., Denayer, E., Taniguchi, K., Kato, R., Somers, R., Messiaen, L., De Schepper, S., Fryns, J. P., Cools, J., Marynen, P., Thomas, G., Yoshimura, A. & Legius, E. (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39, 11201126.
  • Bromberg, Y. & Rost, B. (2007) SNAP: predict effect of non-synonymous polymorphisms on function. Nucl Acids Res 35, 38233835.
  • Cawthon, R. M., Weiss, R., Xu, G. F., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P. & White, P. (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62, 193201.
  • Cichowski, K. & Jacks, T. (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593604.
  • Cnossen, M. H., Van Der Est, M. N., Breuning, M. H., Van Asperen, C. J., Breslau-Siderius, E. J., Van Der Ploeg, A. T., De Goede-Bolder, A., Van Den Ouweland, A. M., Halley, D. J. & Niermeijer, M. F. (1997) Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat 9, 458464.
  • Colman, S. D., Williams, C. A. & Wallace, M. R. (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11, 9092.
  • Danglot, G., Regnier, V., Fauvet, D., Vassal, G., Kujas, M. & Bernheim, A. (1995) Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5’ part of the gene. Hum Mol Genet 4, 915920.
  • Dasgupta, B., Dugan, L. L. & Gutmann, D. H. (2003) The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes. J Neurosci 23, 89498954.
  • DeClue, J. E., Papageorge, A. G., Fletcher, J. A., Diehl, S. R., Ratner, N., Vass, W. C. & Lowy, D. R. (1992) Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69, 265273.
  • Den Dunnen, J. T. & Antonarakis, S. E. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15, 712.
  • Desmet, F. O., Hamroun, D., Lalande, M., Collod-Beroud, G., Claustres, M. & Beroud, C. (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37, e67.
  • Dorschner, M. O., Sybert, V. P., Weaver, M., Pletcher, B. A. & Stephens, K. (2000) NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9, 3546.
  • Fahsold, R., Hoffmeyer, S., Mischung, C., Gille, C., Ehlers, C., Kucukceylan, N., Abdel-Nour, M., Gewies, A., Peters, H., Kaufmann, D., Buske, A., Tinschert, S. & Nurnberg, P. (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66, 790818.
  • Griffiths, S., Thompson, P., Frayling, I. & Upadhyaya, M. (2007) Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer 6, 2134.
  • Gutman, D. H., Andersen, L. B., Cole, J. L., Swaroop, M. & Collins, F. S. (1993) An alternatively-spliced mRNA in the carboxy terminus of the neurofibromatosis type 1 (NF1) gene is expressed in muscle. Hum Mol Genet 2, 989992.
  • Gutmann, D. H., Aylsworth, A., Carey, J. C., Korf, B., Marks, J., Pyeritz, R. E., Rubenstein, A. & Viskochil, D. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278, 5157.
  • Hadfield, K. D., Smith, M. J., Trump, D., Newman, W. G. & Evans, D. G. (2010) SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet 47, 567568.
  • Han, S. S., Cooper, D. N. & Upadhyaya, M. N. (2001) Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 109, 487497.
  • Harder, A., Titze, S., Herbst, L., Harder, T., Guse, K., Tinschert, S., Kaufmann, D., Rosenbaum, T., Mautner, V.F., Windt, E., Wahllander-Danek, U., Wimmer, K., Mundlos, S. & Peters, H. (2010) Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5’ untranslated region, exon and intron 1. Twin Res Hum Genet 13, 582594.
  • Heim, R. A., Kam-Morgan, L. N., Binnie, C. G., Corns, D. D., Cayouette, M. C., Farber, R. A., Aylsworth, A. S., Silverman, L. M. & Luce, M. C. (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4, 97581.
  • Hoffmeyer, S., Nurnberg, P., Ritter, H., Fahsold, R., Leistner, W., Kaufmann, D. & Krone, W. (1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 62, 269277.
  • Hulsebos, T. J., Plomp, A. S., Wolterman, R. A., Robanus-Maandag, E. C., Baas, F. & Wesseling, P. (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80, 805810.
  • Izawa, I., Tamaki, N. & Saya, H. (1996) Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett 382, 5359.
  • Jentarra, G. M., Rice, S. G., Olfers, S., Rajan, C., Saffen, D. M. & Narayanan, V. (2012) Skewed allele-specific expression of the NF1 gene in normal subjects: a possible mechanism for phenotypic variability in neurofibromatosis type 1. J Child Neurol 27, 695702.
  • Kehrer-Sawatzki, H., Kluwe, L., Sandig, C., Kohn, M., Wimmer, K., Krammer, U., Peyrl, A., Jenne, D. E., Hansmann, I. & Mautner, V. F. (2004) High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75, 410423.
  • Klose, A., Ahmadian, M. R., Schuelke, M., Scheffzek, K., Hoffmeyer, S., Gewies, A., Schmitz, F., Kaufmann, D., Peters, H., Wittinghofer, A. & Nurnberg, P. (1998) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet 7, 12611268.
  • Kluwe, L., Siebert, R., Gesk, S., Friedrich, R. E., Tinschert, S., Kehrer-Sawatzki, H. & Mautner, V. F. (2004) Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene. Hum Mutat 23, 111116.
  • Lazaro, C., Gaona, A., Ainsworth, P., Tenconi, R., Vidaud, D., Kruyer, H., Ars, E., Volpini, V. & Estivill, X. (1996) Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 98, 696699.
  • Legius, E., Marchuk, D. A., Collins, F. S. & Glover, T. W. (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3, 122126.
  • Leppig, K. A., Kaplan, P., Viskochil, D., Weaver, M., Ortenberg, J. & Stephens, K. (1997) Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am J Med Genet 73, 197204.
  • Li, Y., O'Connell, P., Breidenbach, H. H., Cawthon, R., Stevens, J., Xu, G., Neil, S., Robertson, M., White, R. & Viskochil, D. (1995) Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25, 918.
  • Lopez Correa, C., Brems, H., Lazaro, C., Estivill, X., Clementi, M., Mason, S., Rutkowski, J. L., Marynen, P. & Legius, E. (1999) Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat 14, 387393.
  • Luijten, M., Redeker, S., Minoshima, S., Shimizu, N., Westerveld, A. & Hulsebos, T. J. (2001) Duplication and transposition of the NF1 pseudogene regions on chromosomes 2, 14, and 22. Hum Genet 109, 109116.
  • Mangoura, D., Sun, Y., Li, C., Singh, D., Gutmann, D. H., Flores, A., Ahmed, M. & Vallianatos, G. (2006) Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene 25, 735745.
  • Marchuk, D. A., Saulino, A. M., Tavakkol, R., Swaroop, M., Wallace, M. R., Andersen, L. B., Mitchell, A. L., Gutmann, D. H., Boguski, M. & Collins, F. S. (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11, 931940.
  • Martin, G. A., Viskochil, D., Bollag, G., Mccabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'connell, P., Cawthon, R. M., Innis, M. A. & McCormick, F. (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63, 843849.
  • Mattocks, C., Baralle, D., Tarpey, P., Ffrench-Constant, C., Bobrow, M. & Whittaker, J. (2004) Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11–17 distinct from the GAP related domain. J Med Genet 41, e48.
  • Maynard, J., Krawczak, M. & Upadhyaya, M. (1997) Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99, 674676.
  • Messiaen, L. & Wimmer, K. (2008) NF1 mutational spectrum. In: Neurofibromatoses (ed. D. Kaufman). Basel: Karger.
  • Messiaen, L. & Wimmer, K. (2012) Mutation analysis of the NF1 gene by cDNA-based sequencing of the coding region. In: Advances in Neurofibromatosis Research (eds. K. S. G. Cunha & M. Geller). New York: Nova Science.
  • Messiaen, L., Callens, T., De Paepe, A., Craen, M. & Mortier, G. (1997) Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum Genet 101, 7580.
  • Messiaen, L., Yao, S., Brems, H., Callens, T., Sathienkijkanchai, A., Denayer, E., Spencer, E., Arn, P., Babovic-Vuksanovic, D., Bay, C., Bobele, G., Cohen, B.H., Escobar, L., Eunpu, D., Grebe, T., Greenstein, R., Hachen, R., Irons, M., Kronn, D., Lemire, E., Leppig, K., Lim, C., Mcdonald, M., Narayanan, V., Pearn, A., Pedersen, R., Powell, B., Shapiro, L. R., Skidmore, D., Tegay, D., Thiese, H., Zackai, E. H., Vijzelaar, R., Taniguchi, K., Ayada, T., Okamoto, F., Yoshimura, A., Parret, A., Korf, B. & Legius, E. (2009) Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome. JAMA 302, 21112118.
  • Messiaen, L. M., Callens, T., Roux, K. J., Mortier, G. R., De Paepe, A., Abramowicz, M., Pericak-Vance, M. A., Vance, J. M. & Wallace, M. R. (1999) Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing. Genet Med 1, 248253.
  • Messiaen, L. M., Callens, T., Mortier, G., Beysen, D., Vandenbroucke, I., Van Roy, N., Speleman, F. & Paepe, A. D. (2000) Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 15, 541555.
  • NIH (1988) Neurofibromatosis. conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45, 575578.
  • Park, V. M., Kenwright, K. A., Sturtevant, D. B. & Pivnick, E. K. (1998) Alternative splicing of exons 29 and 30 in the neurofibromatosis type 1 gene. Hum Genet 103, 382385.
  • Raponi, M., Buratti, E., Dassie, E., Upadhyaya, M. & Baralle, D. (2009) Low U1 snRNP dependence at the NF1 exon 29 donor splice site. FEBS J 276, 20602073.
  • Rasmussen, S. A., Colman, S. D., Ho, V. T., Abernathy, C. R., Arn, P. H., Weiss, L., Schwartz, C., Saul, R. A. & Wallace, M. R. (1998) Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 35, 468471.
  • Rasmussen, S. A., Overman, J., Thomson, S. A., Colman, S. D., Abernathy, C. R., Trimpert, R. E., Moose, R., Virdi, G., Roux, K., Bauer, M., Rojiani, A. M., Maria, B. L., Muir, D. & Wallace, M. R. (2000) Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 28, 425431.
  • Reese, M. G., Eeckman, F. H., Kulp, D. & Haussler, D. (1997) Improved splice site detection in Genie. J Comput Biol 4, 311323.
  • Sawada, S., Florell, S., Purandare, S. M., Ota, M., Stephens, K. & Viskochil, D. (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 14, 110112.
  • Sestini, R., Bacci, C., Provenzano, A., Genuardi, M. & Papi, L. (2008) Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29, 227231.
  • Shannon, K. M., O'Connell, P., Martin, G. A., Paderanga, D., Olson, K., Dinndorf, P. & McCormick, F. (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330, 597601.
  • Sharif, S., Upadhyaya, M., Ferner, R., Majounie, E., Shenton, A., Baser, M., Thakker, N. & Evans, D. G. (2011) A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet 48, 256260.
  • Toliat, M. R., Erdogan, F., Gewies, A., Fahsold, R., Buske, A., Tinschert, S. & Nurnberg, P. (2000) Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b. Electrophoresis 21, 541544.
  • Valero, M. C., Martin, Y., Hernandez-Imaz, E., Marina Hernandez, A., Melean, G., Valero, A. M., Javier Rodriguez-Alvarez, F., Telleria, D. & Hernandez-Chico, C. (2011) A highly sensitive genetic protocol to detect NF1 mutations. J Mol Diagn 13, 113122.
  • Vandenbroucke, I., Vandesompele, J., De Paepe, A. & Messiaen, L. (2002) Quantification of NF1 transcripts reveals novel highly expressed splice variants. FEBS Lett 522, 7176.
  • Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., White, R. & O'Connell, P. (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62, 187192.
  • Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., Brownstein B. & Collins, F. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249, 181186.
  • Weinstein, L. S., Liu, J., Sakamoto, A., Xie, T. & Chen, M. (2004) Minireview: GNAS: normal and abnormal functions. Endocrinology 145, 54595464.
  • Wimmer, K., Yao, S., Claes, K., Kehrer-Sawatzki, H., Tinschert, S., De Raedt, T., Legius, E., Callens, T., Beiglbock, H., Maertens, O. & Messiaen, L. (2006) Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 45, 265276.
  • Xu, G. F., O'connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R. & Weiss, R. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599608.
  • Xu, W., Mulligan, L. M., Ponder, M. A., Liu, L., Smith, B. A., Mathew, C. G. & Ponder, B. A. (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis. Genes Chromosomes Cancer 4, 337342.
  • Yunoue, S., Tokuo, H., Fukunaga, K., Feng, L., Ozawa, T., Nishi, T., Kikuchi, A., Hattori, S., Kuratsu, J., Saya, H. & Araki, N. (2003) Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J Biol Chem 278, 2695826969.
  • Zatkova, A., Messiaen, L., Vandenbroucke, I., Wieser, R., Fonatsch, C., Krainer, A. R. & Wimmer, K. (2004) Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1. Hum Mutat 24, 491501.